WPRIM Management System> DCMS> Journal of Experimental Hematology> 2013> 21> 3

Volume: 21 Issue: 3

1. Relationship between microRNA-155 and hematological malignancies. Page:810—814
2. Influence of miRNA-155 on lymphoma. Page:806—809
3. Research advance in von Willebrand factor. Page:801—805
4. Progress of study on PML in cancer stem cell of hematologic malignancies. Page:796—800
5. Progress of studies on genetics of childhood acute leukemia. Page:791—795
6. Research advances in value of flow cytometric immunophenotyping in diagnosis and prognostic evaluation of myelodysplastic syndrome. Page:785—790
7. Identification and genotyping of difficult blood groups in the patients with phymatosis. Page:780—784
8. Effects of different lyophilizing protectants on lyophilized trehalose-loading red blood cells. Page:775—779
9. Mechanism of MBL inhibiting the LPS-induced DC maturation. Page:770—774
10. Therapeutic effect of human bone marrow mesenchymal stem cell lysates on rat arthritis induced by collagen. Page:765—769
11. Human umbilical cord mesenchymal stem cells reduce the sensitivity of HL-60 cells to cytarabine. Page:760—764
12. Isolation and biological characteristics of mesenchymal stem cells derived from human placenta decidua basalis. Page:754—759
13. Mesenchymal stem cells and endothelial progenitor cells obtained from rabbit bone marrow with differential adhesion methods and their biological characteristics. Page:746—753
14. Effect of SNS-032 on biological activity of hematopoietic stem cells in mice. Page:741—745
15. Knockdown of Larp4b in Lin(-) cells does not affect the colony forming ability of mouse hematopoietic cells. Page:735—740
16. Efficient reprogramming of human cord blood CD34(+) cells for formation of induced pluripotent stem cells with non-integrating plasmid system. Page:728—734
17. Different changes of serum cytokines following HLA-identical and HLA haploidentical non-myeloablative allogeneic hematopoietic stem cell transplantation. Page:721—727
18. Curative effect of human umbilical cord mesenchymal stem cells for treatment of acute graft-versus-host disease of children after allo-HSCT. Page:716—720
19. Treatment of leukemia with immunized donor cell infusion after nonmyeloablative haploidentical bone marrow transplantation. Page:711—715
20. HLA antigen compatibility between patients with hematologic diseases and their parents. Page:707—710
21. Analysis of T lymphocyte absolute number and function in the early phase after haploidentical hematopoietic stem cell transplantation. Page:702—706
22. Efficacy analysis of unrelated donor hematopoietic stem cell transplantation for treatment of high risk acute myeloid leukemia. Page:696—701
23. Type III familial hemophagocytic lymphohistiocytosis susceptibility gene UNC13D involves in homologous recombination repair. Page:692—695
24. Relationship between HLA-A, B alleles and red blood cell parameters of patients with --(SEA/αα) subtype of α(0)-thalassemia of Han ethnic population of Wuzhou city. Page:688—691
25. Expression and significance of vitamin D and its receptor mRNA in the peripheral blood of initial immune thrombocytopenic patients. Page:684—687
26. Tissue factor expression of platelets and leukocytes in patients with acute coronary syndromes. Page:678—683
27. Evaluation of a new method and instrument for detection platelet aggregation function and its clinical application. Page:674—677
28. Transgenic mouse models of the truncated platelet integrin β3 cytoplasmic tail established by stem cell transplantation. Page:667—673
29. Clinical efficacy of decitabine plus improved CAG chemotherapy and haplo-identical donor peripheral lymphocyte infusion regimen on elderly patients with high risk myelodysplastic syndrome and acute myeloid leukemia. Page:662—666
30. Diagnostic value of dysplasia characteristics in typing of myelodysplastic syndrome. Page:657—661
31. Study of the clonal origin and development of MDS by FISH analysis of dysplasia cells in bone marrow of patients with MDS. Page:650—656
32. Therapeutic efficacy analysis of VD regimen and VAD regimen for multiple myeloma. Page:647—649
33. Mechanisms of ROS in U266 cell death induced by FTY720. Page:643—646
34. Relation of B7-H3 molecule expression in multiple myeloma with poor prognosis and bone destruction. Page:637—642
35. Autoimmune hemolytic anemia associated with B-cell chronic lymphoproliferative disorders. Page:633—636
36. Effect of BCL11A gene on transcription of γ-globin gene. Page:628—632
37. Influence of transplantation and some clinical factors on prognosis of patients with diffuse large B-cell lymphoma. Page:623—627
38. Autologous hematopoietic stem cell transplantation for patients with diffuse large B-cell lymphoma: a retrospective study. Page:617—622
39. Demethylation effect of inhibitor As2O3 on expression of SHP-1 and C-kit genes in leukemia HL-60 cells. Page:613—616
40. Mutation of isocitrate dehydrogenase 2 (IDH2) gene in Chinese AML patients and its clinical significance. Page:607—612
41. Detection of NPM1, FLT3 and C-KIT mutations in acute myeloid leukemia and their prognostic analysis. Page:601—606
42. Clinical characteristics of CD56(+) patients with acute monocytic leukemia and their prognostic significance. Page:596—600
43. Mitochondrial mechanisms of apoptosis of human leukemia K562 cells induced by AVVC-1. Page:591—595
44. Influence of TIEG1 on apoptosis of HL-60 cells and expression of Bcl-2/Bax. Page:587—590
45. Efficacy of dasatinib in treatment of imatinib-resistant BCR/ABL positive leukemia. Page:581—586
46. Transfection of HL-60 cells by Venus lentiviral vector. Page:576—580
47. Correlation of NPM1, FLT3-ITD mutations with leukocyte count and myeloblasts percentage in AML patients with normal karyotype. Page:571—575
48. Construction of shRNA expression vector targeting AATF and establishment of stably transfected U937 cells. Page:567—570
49. Analysis of bone marrow and peripheral blood cytologic features in hyperleukocytic acute leukemia. Page:562—566
50. Expression of microRNA-223 in lymphocytic leukemia cells and its action mechanism. Page:556—561
51. Effects of transcription factor GATA-2 on transcriptive regulation of iASPP gene. Page:550—555
52. Dual over-expression of P2X7 receptor and intracellular domain of Notch1 in leukemia cells. Page:544—549
53. Expression and clinical significance of IKZF1 gene IK6 isoform in adult acute lymphoblastic leukemia. Page:539—543